Allergy symptom scoring (gastrointestinal, respiratory, skin, and systemic allergy reflections); inflammatory factors (TNFα/IL-1β/IL-6/IL-10); antibodies (IgE/IgG2); efficacy in eczema reduction. This evidence concerns the gene IL1B and Eczematoid dermatitis.